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Abstract
Background Despite the many studies on chondral injury
repair, no outcomes have been evaluated with the Western
Ontario and McMaster (WOMAC) Universities osteoar-
thritis index, the Knee Injury and Osteoarthritis Outcome
Score (KOOS), and the Oxford Knee Score, all of which
are speciﬁc for evaluating the presence of osteoarthritis.
Materials and methods We evaluated the clinical pro-
gress of patients following autologous chondrocyte
implantation (ACI) performed by our Bone and Tissue
Bank using a technique in which cells, instead of being
introduced to the articular defect in a liquid form, are
implanted into a tridimensional matrix of semisolid colla-
gen (Condrograft
). A total of 22 patients underwent the
procedure, 15 of whom were available for a 1-year follow-
up that included clinical evaluation by WOMAC score
before and after surgery and KOOS and the Oxford Knee
Score after surgery.
Results The results were improved WOMAC score from
56.4 before surgery to 16.2 after surgery (P\0.002),
average KOOS score of 83.6, and average Oxford Knee
Score of 18.8.
Conclusions These results indicate that our tridimen-
sional matrix technique effectively improved patients’
quality of life, at least in the short term, and delayed any
subsequent procedure. Long-term assessment is necessary
to determine the true value of this technique.
Keywords Tridimensional matrix   WOMAC score  
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Introduction
Injuries to the articular cartilage are complex and difﬁcult
to repair, due mainly to the poor capacity of this tissue to
repair itself, which produces a scar tissue with histological
and biomechanical characteristics inferior to the original
cartilage. This can create failures in the injured joint, which
can cause arthritis [1]. Different repair techniques, such as
microfractures, mosaicplasty, and osteochondral allograft,
among others, have attained positive results [2–6]. Britt-
berg et al. [2], in 1994, reported autologous chondrocyte
implantation (ACI) as being an effective technique for
repairing articular defects. The original technique required
injecting cells into the chondral defect, and these cells were
covered with a periosteal patch that, due to its chondro-
genic potential, allowed tissue repair with histological
characteristics similar to the hyaline cartilage [2, 7, 8]. This
technique requires more time in surgery, and complications
such as hypertrophy and delamination have been reported
with the use of periosteum [6, 8–11].
In our Bone and Tissue Bank, we are attempting to
improve the ACI method by using a technique in which
cells, instead of being introduced to the articular defect in a
liquid form, are implanted into a tridimensional matrix of
semisolid collagen (Condrograft
). In this way, the graft is
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not require the periosteum patch, and requires less surgical
time. In this paper, we report our clinical assessment of
patients treated with this tridimensional matrix, using
speciﬁc scores for patients with osteoarthritis [Western
Ontario and McMaster (WOMAC) Universities osteoar-
thritis index, the Knee Injury and Osteoarthritis Outcome
Score (KOOS) and the Oxford Knee Score], because we
found no records that use this type of evaluation.
Materials and methods
We considered all patients who underwent an ACI, and
whose cells were processed in our Bone and Tissue Bank,
between January 2005 and September 2007. A total of 22
patients underwent ACI; seven were excluded, of whom
three were subjected to implant in talus bone and the
remaining patients either did not respond or did not agreed
to the interview. We therefore followed 15 patients, of
whom six were men and nine were women, with a mean
age of 42.5 (29–54) years.
The inclusion criteria were knee pathology, chondral
defectsdemonstratedbymagneticresonanceimaging(MRI)
and/orarthroscopy,injuriesof1.5–8 cm
2,nokneeinstability
(anterior, posterior, or lateral), and no injuries on ‘‘mirror.’’
Exclusion criteria were having had surgery in a previously
injured area, preliminary procedures for treating chondral
injuries, osteoarthritis (OA) of two or more knee compart-
ments, and refusal of the proposal and evaluation technique.
Patients who did not complete the assessment or who were
without an effective follow-up were eliminated. All patients
provided written informed consent to participate.
All patients underwent arthroscopic surgery to obtain a
biopsy of autologous chondrocyte. The cells were then pro-
cessed through the standard technique [12], and when the
cellularcountwasconsideredhighenough,cellswereplaced
in a tridimensional matrix (Condrograft
) and the implan-
tation performed using a minimum arthrotomy, lateral or
medial, depending on injury site. The matrix was ﬁxed by
suturesthroughdrillholesinthebone,andtheprocedurewas
performed by placing cuff ischemia in the upper third of the
thigh. The immediate postoperative protocol was similar for
all patients; they were sent home between 1 and 2 days after
surgery, with no weight bearing permitted for 4 weeks to
enable proper adherence of the patch. After this period, the
criterionforrehabilitationwascarriedoutbythephysicianin
charge of the patients and their rehabilitation team.
Accordingtothiscriterion,patientswereallowedtomoveon
demand as ﬂexibility increased.
All patients were evaluated using the WOMAC score
before and after surgery, and the Oxford Knee Score and
KOOS after surgery. Postsurgical evaluation was carried
out a year after surgery. The WOMAC score evaluates
knee OA, but not appearance or function, ability to perform
sports, or quality of life. The KOOS, as an extension of the
WOMAC score, allows evaluation of young patients with
knee injury over the short and long term on ﬁve subscales:
Pain, Other Symptoms, Daily Living Activities, Sport and
Recreation Function, and Quality of Life. The Oxford Knee
Score consists of 12 questions and assesses good function
or the need for further treatment [13–17]. Our study was
approved by the ethical committee of our hospital, in
accordance with the Declaration of Helsinki.
Statistical analysis
We conducted the Wilcoxon signed ranks test and the sign
test, with correlated data with a reliability of 95%. Eval-
uation included the WOMAC score before and after sur-
gery, as well as analysis by gender and affected side.
Signiﬁcance was set at P\0.05, and the statistics program
STATA-IC-10 was used for statistical analysis.
Results
Of the 15 patients studied, six were men and nine were
women, with an age average of 42.5 (range 29–54) years.
As for the side of the injury, seven were left and eight were
right. Regarding lesion location, nine were in the lateral
condyle, four were medial, one was a patella lesion, and
one involved both condyles (Table 1).
WOMAC score before surgical procedure
WOMAC score before surgery was 56.4 points (22–96).
Grouped by gender, men scored 52.5 (28–81) and women
59 (22–96). Patients with a left-sided injury scored 59.8
(28–96) before surgery, whereas those with a right-sided
injury scored 51.5 (22–87). According to injury location,
patients with an injured lateral condyle scored a mean of
46.2 (22–87), whereas those with medial-side injury scored
69.2 (51–96). The patient injured in both condyles scored
72, whereas the patient with a patella injury scored 81
(Table 2).
WOMAC score after surgical procedure
All but two patients showed improvement after surgery,
with a mean WOMAC score of 16.2 (2–74). The average
score for men was 11.1 (5–23) and for women, 19.7 (2–74).
Patients with left-sided injury scored an average of 18.4 (2–
74) and those with right-sided injury 15.1 (4–37). In
patients with lateral injury, WOMAC improved to 12.1 (4–
37), and patients with medial injury scored a mean of 9.75
174 J Orthopaed Traumatol (2009) 10:173–177
123(2–14). The patient with a lesion on both condyles showed
a worsened score after surgery (74), whereas the score for
the patient with patella injury improved to 23 (Table 2).
Oxford Knee Score
The average Oxford Knee Score was 18.8 (14–31), which
indicates a satisfactory joint function for all patients. Men
had an average score of 16.8 (14–19), whereas women
averaged 20.1 (15–31). Patients with left-sided injuries
scored an average of 18.5 (14–31) and those with right-
sided injuries an average of 19 (15–28). In general, in all
groups, a score \20 was obtained. Patients with lateral
condyle injury scored an average of 17.5 (14–28) and those
with medial injury 18.5 (17–19). The patient with a lesion
on both condyles scored 31, a level of moderately severe
osteoarthritis, whereas the patient with patella injury scored
19 (Table 2).
KOOS
The average KOOS was 83.6 (41–95). Men scored an
average of 88.1 (79–95), whereas women scored an aver-
age of 80.5 (41–92). Patients with left-sided injury scored
an average of 82.4 (41–95), whereas those with right-sided
injury scored an average of 83.9 (67–92). Patients with
lateral condyle injury scored a mean of 86.7 (67–95), and
those with medial condyle injury scored 88.2 (85.1–92.2).
Patients with both condyles injured scored 41.07, whereas
patients with an injured patella scored 79.16 (Table 2).
Comparison of WOMAC scores
WOMAC score before surgery was 56.4 points and after
surgery 16.33 (P\0.002 on Wilcoxon signed ranks test
and P\0.007 on Sign test), which was a statistically
signiﬁcant difference. Women before surgery scored 59
points and after surgery 19.7 (P\0.0033); men before
surgery scored 52.5 points and after surgery 11.1 points
(P\0.0001). Patients affected on the left side scored 60
points before surgery and 18.4 points after surgery
(P\0.0025). Result for the right side before surgery was
53 points and after surgery 15.1 points (P\0.0002)
(Table 2). These results showed a statistically signiﬁcant
difference.
Discussion
There have been reports about treatment of chondral inju-
ries with bilayer devices of collagen compared with pig
collagen type I/III in which the same results were reported
with both techniques [18]. Other alternatives have been
described, such as reabsorbable membrane Chondroid-
glide (collagen type I/III membrane), and clinical outcomes
with this type of membrane seem promising [19, 20]. There
have been reports of good short-term results using a scaf-
fold biodegradable polymer-based hyaluronan HYAff-11
[21]. We believe that our tridimensional matrix is just as
effective as other implants, as we create a semisolid
environment that allowed cells to better establish and be
Table 1 Overview of patient
data
Mean of patients by sex and
total average
WOMAC Western Ontario and
McMaster Universities
osteoarthritis index, KOOS
Knee Injury and Osteoarthritis
Ourtome Score
Men Women Total average (range)
Number of patients 6 9
Age 43.1 (38–53) 42.1 (29–54) 42.5 (29–54)
WOMAC score before surgery 52.5 (28–81) 59 (22–96) 56.4 (22–96)
WOMAC score after surgery 11.1 (5–23) 19.7 (2–74) 16.2 (2–74)
KOOS 88.1 (79–95) 80.5 (41–92) 83.6 (41–95)
Oxford Knee Score 16.8 (14–19) 20.1 (15–31) 18.8 (14–31)
Table 2 Data pertaining to injury site
Age WOMAC before WOMAC after KOOS Oxford Knee Score
Medial condyle 42.2 (29–53) 46.2 (22–87) 12.1 (4–37) 86.7 (67–95) 17.5 (14–28)
Lateral condyle 41.5 (29–56) 69.2 (51–96) 9.7 (2–14) 88.2 (85–92) 18.5 (17–19)
Both condyles
a 54 72 74 41 31
Patella
a 38 81 23 79 19
WOMAC Western Ontario and McMaster Universities osteoarthritis index, KOOS Knee Injury and Osteoarthritis Outcome Score
a In both cases, single-patient data
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123properly maintained at the injury site. In addition, our
clinical results in the short term are promising.
We chose the Oxford, WOMAC, and KOOS, as these
methods indicate development of OA and have proven
their reliability in assessing and evaluating such patients.
KOOS is an extension of WOMAC [13] and was developed
for the evaluation of young patients with knee injury or OA
in the short- and long term. It consists of 42 items separated
into ﬁve subscales: Pain, Other Symptoms, Daily Living
Activities, Sports and Recreation Function, and Quality of
Life. There are ﬁve possible answers in each subscale with
a value from 0 (no problem) to 4 (extreme problem) ranked
on a scale of 0–100, where 0 represents extreme knee
problems and 100 trouble free [14, 15]. Two advantages
with KOOS compared with WOMAC are the subscale of
Sports and Recreation Function, as well as Quality of Life,
because patients with OA subjected to procedures for their
improvement, manifested a signiﬁcant breakthrough in
these parameters [14].
After a year of evaluation, we found a signiﬁcant
improvement of symptoms in the WOMAC score. Patients
obtained 56.4 points before surgery and 16.2 points a year
after the procedure. Bentley et al. [22], in 2003, compared
the use of mosaicplasty with ACI and found good and
excellent results in 88% of patients treated with ACI and
69% in patients treated with mosaicplasty using the
Cincinnati Score and Stanmore Score after a year of
assessment.
Mitho ¨fer et al. [23] conducted a study in soccer players
in whom ACI was performed and found a 72% good to
excellent results with a Tegner Activity Score, plus 33% of
their patients returned to physical activity. In our results,
the Oxford score was 18.8 points, which is considered
within normal limits, without details of OA, whereas with
KOOS, the result was 83.6 points out of a possible 100,
which placed our patients in a very acceptable position
according to assessment by that score. In addition, Krish-
nan et al. [24] found improvement in the Cincinnati Score
from 46.1 to 68.4 in patients treated with ACI, with good to
excellent results in 82% of patients with juvenile onset of
osteochondritis dissecans compared with 44.4% of those
with adult onset of disease. Bartlett et al. [18], in a pre-
liminary report, valued the ACI with a bilayer membrane
of collagen, modifying the original technique of ‘‘sand-
wich,’’ avoiding the use of periosteum. They evaluated
patients with a modiﬁed Cincinnati Score, analogue scale
for pain, and functional Stanmore Score. All patients
improved after 6 months and even further after a year.
They ranked good to excellent after 6 months. Wood et al.
[25] reported 497 adverse effects in 294 patients receiving
Carticel, of whom 96% of had femoral condyle injuries.
The most reported side effect was graft failure in 25%,
delamination in 22%, and implant hypertrophy 18%. There
were also 18 infections reported: seven soft tissue and 11
joint infections; in general, there were adverse effects in
3.8% of patients treated with this method between 1995
and 2002.
Among the limitations of our study was the need to
conduct a long-term assessment, complemented with clin-
ical results of MRI images, as well as the lack of a second-
look arthroscopy to assess membrane integration. These
data would complement the clinical assessment. We
concluded that ACI with our tridimensional membrane
(Condrograft
) is a good treatment option for patients with
osteochondral injuries that meet certain criteria. In addition
to the clinical results obtained by our study, patients
improved signiﬁcantly after application of this technique.
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